CD34 and acute myeloid leukemia: We chose the MN1 oncogene for this approach as transduction of MN1 in CD34 + cord blood cells promotes self-renewal in vitro and engraftment in vivo, but does not induce AML in vivo nor does it enable serial transplantation [28].